Tommaso Fava

Here below are the publications (2) participated by Tommaso Fava along with Alessandra Franzetti Pellanda (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein

Science Immunology, 26 gennaio 2023

2) Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2

bioRxiv, 28 novembre 2022

Facts & figures

Tommaso Fava has coordinated or participated in 2 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 3 elements tag cloud:

SARS-CoV-2 (2) antibodies (1) glycoprotein (1)

Tommaso Fava has coordinated or participated in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 2 scientific journals:

bioRxiv (1) Science Immunology (1)

Tommaso Fava has coordinated or participated in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 24 co-authors being active in Ticino:

Lucie Podesvova (2) Luca Simonelli (2) Jacopo Sgrignani (2) Davide Robbiani (2) Christian Garzoni (2) Andrea Celoria (2) Tomas Cervantes Rincon (2) Alessandra Franzetti Pellanda (2) Milos Matkovic (2) Maira Biggiogero (2) Luca Varani (2) Jonathan Muri (2) Filippo Bianchini (2) Concetta Guerra (2) Virginia Crivelli (2) Chiara Toscano (2) Andrea Cavalli (2) Raoul De Gasparo (2) Akanksha Shanbhag (2) Mattia Pedotti (2) Veronia Calvaruso (1) David Jarrossay (1) Veronica Calvaruso (1) Mariagrazia Uguccioni (1)

Tommaso Fava has coordinated or participated in 2 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 5 most frequently used terms (excluding 9 not relevant terms) are here listed:

T.F. WORD CLOUD antibodies (2) epitopes (2) sars-cov (2) spike (1) glycoprotein (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 9 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Il mondo delle startup

Tommaso Fava has participated - as a whole - in 2 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Alessandra Franzetti Pellanda

1) Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein

2) Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2

Tommaso Fava has participated - as a whole - in 2 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Alessandra Franzetti Pellanda